Gliosarcoma with Systemic Metastasis Showing Favorable Response to Ifosfamide, Carboplatin, and Etoposide Chemotherapy: An Autopsy Case Report-Reference-Cited by-同舟云学术

Gliosarcoma with Systemic Metastasis Showing Favorable Response to Ifosfamide, Carboplatin, and Etoposide Chemotherapy: An Autopsy Case Report

Published:2022-12-31 Issue:0 Volume:9 Page:263-268
ISSN:2188-4226
Container-title:NMC Case Report Journal
language:en
Short-container-title:

Author:

NAKAGAKI Yuki¹,KAI Keitaro¹,KOMOHARA Yoshihiro²,TAKEZAKI Tatsuya¹,KURODA Junichiro¹,SHINOJIMA Naoki³,SHIMOMURA Mari³,KAWAKAMI Fumi³,MIKAMI Yoshiki³,MUKASA Akitake¹

Affiliation:

1. Department of Neurosurgery, Graduate School of Medical Sciences, Kumamoto University

2. Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University

3. Department of Diagnostic Pathology, Graduate School of Medical Sciences, Kumamoto University

Publisher

Japan Neurosurgical Society

Subject

Polymers and Plastics,General Environmental Science

Link

https://www.jstage.jst.go.jp/article/nmccrj/9/0/9_2022-0075/_pdf

Reference12 articles.

1. 1) Lun M, Lok E, Gautam S, Wu E, Wong ET: The natural history of extracranial metastasis from glioblastoma multiform. J Neurooncol 105: 261-273, 2011

2. 2) Beaumont TL, Kupsky WJ, Barger GR, Sloan AE: Gliosarcoma with multiple extracranial metastases: case report and review of the literature. J Neurooncol 83: 39-46, 2007

3. 3) Smith DR, Wu CC, Saadatmand HJ, et al.: Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma. J Neurooncol 137: 303-311, 2018

4. 4) Damodaran O, van Heerden J, Nowak AK, et al.: Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy. J Clin Neurosci 21: 478-481, 2014

5. 5) Han SJ, Yang I, Ahn BJ, et al.: Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients. Cancer 116: 1358-1366, 2010